Blood product transfusion practices in neonates with hypoxic-ischemic encephalopathy

Area of Science:

• Neonatalogy
• Pediatric Critical Care
• Hematology

Background:

• Therapeutic hypothermia (TH) is standard for hypoxic-ischemic encephalopathy (HIE).
• Blood product transfusion is common in HIE infants during TH.
• Transfusion practices and their impact in this population are not well understood.

Purpose of the Study:

• To describe blood product transfusion practices in infants with HIE.
• To examine the association between transfusion practices and infant outcomes.

Main Methods:

• Retrospective cohort study at a single Level IV NICU.
• Evaluation of transfusion thresholds.
• Analysis of hematological abnormalities and blood product transfusions in relation to outcomes.

Main Results:

• Univariate analysis suggested FFP transfusion was linked to increased in-hospital death.
• Multivariate analysis, controlling for HIE severity, found no association between transfusion and death.
• No association was observed between transfusion and neurodevelopmental impairment.

Conclusions:

• Blood product transfusion in HIE infants during TH was not associated with death or neurodevelopmental impairment in this study.
• Findings suggest current transfusion practices may be safe, but further investigation is warranted.
• Optimal transfusion thresholds for HIE infants require further study.